Brief: Zentalis Pharmaceuticals Q1 Operating Expenses USD 65.325 Million
07/05/2024 12:00
May 07 (Reuters) - Zentalis Pharmaceuticals Q1 operating income USD -24.765 million. * Q1 net income USD 10.04 million * Q1 pretax profit USD 10.183 million
Recent news on Zentalis Pharmaceuticals
See all newsBrief: Zentalis Pharmaceuticals Says Median Overall Survival Of 15.8 Months With Azenosertib In Cyclin E1-Positive Proc
Brief: Zentalis Pharmaceuticals Announces Inducement Grants Under Nasdaq Listing Rule 5635(C)(4)
U.S. STOCKS ON THE MOVE-Sun Communities, Cisco Systems, Paysafe
U.S. STOCKS ON THE MOVE-Fox, Sun Communities, Reddit, drone firms
U.S. STOCKS ON THE MOVE-Boost Run, Nektar Therapeutics, Swarmer